✦ LIBER ✦

Urinary IL-2 assay for monitoring intravesical bacillus calmette-guérin (BCG) response of superficial bladder cancer during induction course and maintenance therapy

✍ Scribed by F. Saint; P. Maille; D. Vordos; A. Hoznek; P. Soyeux; J.J. Patard; C.C. Abbou; D. Chopin

Book ID: 118644908
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 193 KB
Volume: 2
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(03)80756-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urinary IL-2 assay for monitoring intrav

Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guérin response of superficial bladder cancer during induction course and maintenance therapy

✍ Fabien Saint; Nathalie Kurth; Pascale Maille; Dimitri Vordos; Andre Hoznek; Pasc 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 670 KB

## Abstract We evaluated the clinical significance of Th1(IL‐2)/Th2(IL‐10) urinary profiles during a weekly induction course lasting 6 weeks, followed by a weekly maintenance therapy schedule for 3 weeks. Urinary IL‐2 and /IL‐10 were measured by ELISA in 39 patients receiving BCG for superficial bl

Predictive Markers and Cancer Prevention

Predictive Markers and Cancer Prevention. Urinary IL-2 Assay for Monitoring Intravesical Bacillus Calmette-Guérin Response of Superficial Bladder Cancer During Induction Course and Maintenance Therapy

✍ Droller, Michael J. 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 58 KB

Induction of urinary interleukin-1 (IL-1

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

✍ E. C. De Boer; W. H. De Jong; P. A. Steerenberg; L. A. Aarden; E. Tetteroo; E. R 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 833 KB

Bacillus Calmette-Guérin With or Without

Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder Cancer

✍ Nepple, Kenneth G.; Lightfoot, Andrew J.; Rosevear, Henry M.; O'Donnell, Michael 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 252 KB

Immunohistochemical evaluation of p53, p

Immunohistochemical evaluation of p53, proliferating cell nuclear antigen (PCNA) and bcl-2 expression during bacillus calmette-guerin (BCG) intravesical instillation therapy for superficial bladder cancers

✍ Okamura, Takehiko ;Akita, Hidetoshi ;Kawai, Noriysau ;Tozawa, Keiichi ;Yamada, Y 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 241 KB

491 Evaluation of urine interleukin-2 (I

491 Evaluation of urine interleukin-2 (IL2), IL6 and IL10 levels during intravesical therapy with interferon α-2B (IFNα-2B) alone and IFINα-2B combined with low dose bacillus Calmette-Guérin (BCG) in superficial bladder cancer

✍ L. Özdal; T. Özdemir; K. Yakupoǧlu; S. Bulut; A. Memiş; O. Sariyüce 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 207 KB